Home / Inspections / 1099682

FDA Inspection 1099682 — Ildiko Lingvay, MD

Ildiko Lingvay, MD — FEI 3015357456

The FDA completed an inspection of Ildiko Lingvay, MD on July 12, 2019 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources